In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

'Real Challenge' To Improve OTC Monograph Program Without User Fees – FDA

This article was originally published in The Rose Sheet

Executive Summary

FDA is weighing the potential benefits of, and drawbacks to, establishing user fees to support its OTC drug monograph program, opening a docket for comments and conducting a June 10 public meeting on the subject. Industry seems far from on board at present, and FDA also acknowledges that there could be downsides to a user fee program in addition to potential benefits for companies and consumers.

Advertisement

Related Content

Public Citizen Attempts To Force FDA Decision On Benzocaine Petition
Public Citizen Attempts To Force FDA Decision On Benzocaine Petition
Cosmetic Regulation Update's Link With OTC Drug User Fees Clear At Hearing
Legislators On OTC Monograph Reform: What Took You So Long?
Legislators On OTC Monograph Reform: What Took You So Long?
Gottlieb Recognizes OTC Monograph Woes During Confirmation Hearing
OTC Monograph Woes No Surprise To FDA Commissioner Nominee Gottlieb
OTC Monograph Woes No Surprise To FDA Commissioner Nominee Gottlieb

Topics

Advertisement
UsernamePublicRestriction

Register

RS019954

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel